Rapport Therapeutics, Inc. ($RAPP)
Filing Information
| Accession Number | 0001193125-26-059883 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 20, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
20,500
Total Value
$257,455.05
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Feb 17, 2026 | Sale | 900 | $28.02 | $25,218.99 | 394,675 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Feb 17, 2026 | Sale | 5,400 | $28.95 | $156,328.38 | 389,275 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Feb 17, 2026 | Sale | 2,200 | $29.59 | $65,107.68 | 387,075 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Feb 19, 2026 | Exercise/Conversion | 6,000 | $1.80 | $10,800.00 | 393,075 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Options (Right to Buy) | Derivative | Feb 19, 2026 | Exercise/Conversion | 6,000 | $0.00 | $0.00 | 88,080 | Direct | โ | View Details |